Global discontinuation of market access of the Alcon AcrySof® Cachet™ Phakic Lens due to increase in cases of endothelial cell loss (ECL) among clinical study patients with severe myopia

Alcon Pte Ltd would like to inform healthcare professionals of a global discontinuation of the market access of the Alcon AcrySof® Cachet™ Phakic Intraocular Lens. The voluntarily discontinuation is due to clinical data analysis that indicates an increase in the number of cases of endothelial cell loss among patients with severe myopia. None of the patients with lens explants experienced permanent vision loss. Healthcare professionals are advised to continue monitoring and adhere to the evaluation requirements as outlined in the current Direction for Use for patients implanted with the affected Cachet™ Phakic Intraocular Lens.  Healthcare professionals are advised to refer to the letter for details.

 
 
Healthcare professional, Medical devices
Published:

Dear Healthcare Professional Letters

12 Dec 2019

Only abstracts of the Dear Healthcare Professional Letters (DHCPL) are provided on this website. Details of the letters can be found on the MOH Alert System, which is accessible via the Health Professionals Portal (HPP), a one-stop portal for all healthcare professionals in Singapore. Dentists, medical doctors and pharmacists may access HPP at https://www.hpp.moh.gov.sg and follow the procedures below to access the MOH Alert system.

Step 1: Select your profession under 'For Healthcare Professionals’.

Step 2: Click on 'Restricted Content' and log in via SingPass.

Step 3: Click on the MOH Alert icon under ‘Applications’.

Step 4: Click on the Drug Alert tab to view the DHCPLs.